US 11083799
Materials and methods for treatment of hereditary haemochromatosis
granted A61KA61K48/005A61K48/0058
Quick answer
US patent 11083799 (Materials and methods for treatment of hereditary haemochromatosis) held by CRISPR THERAPEUTICS AG expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K48/005, A61K48/0058, A61K48/0066, A61K48/0075